Patent · US Active

Heterodimeric immunoglobulins

US11466078B2 · kind B2 · utility

0Cited by
66References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 5, 2019
Grant dateOct 11, 2022
Priority date—
Expiry dateDec 25, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application is directed to heterodimeric antibodies and methods of use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.